CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −56,019 | $1.11 | $62K | 616,616 |
| 2026-02-02 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −34,951 | $1.39 | $49K | 672,635 |
| 2026-01-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +204,000 | 707,586 | ||
| 2026-01-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +320,000 | 320,000 | ||
| 2025-06-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −41,314 | $3.67 | $152K | 503,586 |
| 2025-01-31 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +194,900 | 544,900 | ||
| 2025-01-31 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +292,300 | 292,300 | ||
| 2024-06-28 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +350,000 | 350,000 | ||
| 2024-06-28 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +500,000 | 500,000 |
Page 1 of 1 · 9 trades